knowledge -WSS

knowledge

author：comprehensive 2025-10-06 12:19:35 - browse：6

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： New lesbian bars spark hope amid disappearing LGBTQ+ spaces

focus

hotspot

WSS

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Synthetic human embryos? Researchers say term is overblown

Brazil's Jair Bolsonaro is barred from running for office until 2030

Focused ultrasound for uterine fibroids: an uphill battle

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Synthetic human embryos? Researchers say term is overblown

leisure time

knowledge

focus

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

State Dept. review finds Biden bears some blame for Afghanistan failures

Supreme Court strikes down Biden student loan forgiveness program

Novavax promises a turnaround & Lilly roils the obesity market

Illumina to lay off 10% of research and development team

Jerome Adams on the need for new antivirals for Covid

Lab trade group sues FDA to halt regulation of lab

Medical leaders decry Supreme Court decision on affirmative action

iTeos Therapeutics debuts first data on TIGIT

focus

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Lab trade group sues FDA to halt regulation of lab

Tuskegee Airman Raymond Cassagnol dies at 102

The simple reason for the increase in autism diagnosis

Dark money group runs ads on China biotech bill

The simple reason for the increase in autism diagnosis

focus

focus

hotspot

Wikipedia